The pharmaceutical market has been overhauled!Four pharmaceutical companies in Shanghai were fined 1.2 billion yuan for monopoly, and the state took action, and patients finally looked forward to the "drug price" dropping!
Recently, the Shanghai Municipal Administration for Market Regulation announced a major anti-monopoly law enforcement result, and punished Shanghai Shanghai Pharmaceutical First Biochemical Pharmaceutical, Wuhan Huihai Pharmaceutical, Wuhan Kede Pharmaceutical, Hubei Minkang Pharmaceutical, with a total of 12$1.9 billion.
These companies have been accused of unfair sales practices in China's injectable polymyxin sulfate B market.
The Shanghai Municipal Administration for Market Regulation disclosed in detail how the four companies controlled the illegal process of APIs, unfair sales, and monopoly profits through close cooperation.
This punishment is not only a punishment for these four companies, but also a warning to the entire pharmaceutical industry.
The people couldn't help asking: After the price is reduced by 90%, there are still high profits, but how much medical expenses do patients have to bear?
The state's supervision of the pharmaceutical market is constantly being strengthened, and any violation of market rules will be seriously dealt with in accordance with the law.
Medicine is not a tool for profit, but a medicine to save lives.
It is hoped that all medicines can return to a reasonable **, so that patients can really benefit.
What do you think about this?Welcome to the exchange.